NPS Pharmaceuticals Company Profile (NASDAQ:NPSP)

About NPS Pharmaceuticals

NPS Pharmaceuticals logoNPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on delivering therapies that transform the lives of patients with rare diseases. The Company's primary product Gattex 0.05 mg/kg/d (teduglutide [rDNA origin]) for injection, for subcutaneous use was approved the United States Food and Drug Administration (FDA) for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support. The Company's second principal product, Natpara (recombinant human parathyroid hormone 1-84 [rDNA origin] injection, has been developed for hypoparathyroidism, a rare multidimensional disorder characterized by deficient or absent parathyroid hormone (PTH). The Company has collaborations or royalty agreements with Amgen, Janssen, GlaxoSmithKline and Kyowa Hakko Kirin.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NPSP
  • CUSIP: 62936P10
Key Metrics:
  • Previous Close: $46.00
  • 50 Day Moving Average: $0
  • 200 Day Moving Average: $37
  • 52-Week Range: $22.00 - $46.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 23.00
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:
Companies Related to NPS Pharmaceuticals:

Analyst Ratings

Consensus Ratings for NPS Pharmaceuticals (NASDAQ:NPSP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for NPS Pharmaceuticals (NASDAQ:NPSP)
Show:
DateFirmActionRatingPrice TargetDetails
1/14/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$42.00 -> $46.00View Rating Details
1/13/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
1/13/2015Barclays PLCDowngradeOverweight -> Equal Weight$50.00 -> $46.00View Rating Details
1/12/2015CRT CapitalDowngradeBuy -> Fair ValueView Rating Details
1/12/2015Jefferies GroupSet Price TargetHold$26.00 -> $46.00View Rating Details
1/12/2015WedbushDowngradeOutperform -> Neutral$46.00View Rating Details
1/12/2015Canaccord GenuityDowngradeBuy -> Hold$42.00View Rating Details
12/18/2014Sterne Agee CRTInitiated CoverageNeutralView Rating Details
10/24/2014Goldman Sachs Group Inc.DowngradeBuy -> NeutralView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for NPS Pharmaceuticals (NASDAQ:NPSP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/18/2015Q414$0.06($0.02)$69.30 million$66.70 millionViewN/AView Earnings Details
11/10/2014Q314$0.01($0.02)$59.50 million$57.20 millionViewN/AView Earnings Details
8/6/2014Q214$0.02$53.06 million$56.10 millionViewListenView Earnings Details
5/8/2014Q114($0.02)($0.06)$48.30 million$44.04 millionViewListenView Earnings Details
2/27/2014Q413$0.02$0.07$44.22 million$54.45 millionViewListenView Earnings Details
11/6/2013Q313($0.02)($0.01)$38.40 million$39.20 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.13)$31.62 million$36.50 millionViewListenView Earnings Details
5/9/2013Q1 2013($0.13)($0.09)$27.56 million$25.43 millionViewListenView Earnings Details
2/21/2013Q4 2012($0.09)($0.14)$28.93 million$27.10 millionViewListenView Earnings Details
11/9/2012Q312($0.16)($0.04)$28.18 million$27.02 millionViewN/AView Earnings Details
8/1/2012($0.09)$0.08ViewN/AView Earnings Details
5/3/2012($0.11)($0.12)ViewN/AView Earnings Details
2/15/2012($0.11)($0.10)ViewN/AView Earnings Details
11/3/2011($0.10)($0.14)ViewN/AView Earnings Details
8/2/2011($0.07)($0.07)ViewN/AView Earnings Details
5/3/2011($0.12)($0.13)ViewN/AView Earnings Details
2/15/2011($0.20)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NPS Pharmaceuticals (NASDAQ:NPSP)
Current Year EPS Consensus Estimate: $1 EPS
Next Year EPS Consensus Estimate: $2 EPS

Dividends

Dividend History for NPS Pharmaceuticals (NASDAQ:NPSP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NPS Pharmaceuticals (NASDAQ:NPSP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/10/2015Susan E GrafVPSell6,711$45.87$307,833.57View SEC Filing  
12/17/2014Joseph J RogusSVPSell16,467$35.00$576,345.00View SEC Filing  
12/17/2014Luke M BesharCFOSell52,258$35.00$1,829,030.00View SEC Filing  
12/17/2014Rachel R SeliskerDirectorSell3,708$34.59$128,259.72View SEC Filing  
12/8/2014Rachel R SeliskerDirectorSell23,157$34.50$798,916.50View SEC Filing  
11/28/2014Rachel R SeliskerDirectorSell11,635$34.50$401,407.50View SEC Filing  
11/17/2014Joseph J RogusSVPSell26,782$30.00$803,460.00View SEC Filing  
11/11/2014Rachel R SeliskerDirectorSell15,188$29.50$448,046.00View SEC Filing  
10/31/2014Luke M BesharCFOSell10,000$29.00$290,000.00View SEC Filing  
10/27/2014Luke M BesharCFOSell30,635$26.75$819,486.25View SEC Filing  
2/13/2014Georges GemayelDirectorSell6,188$37.70$233,287.60View SEC Filing  
1/8/2014Luke BesharCFOSell31,588$35.01$1,105,895.88View SEC Filing  
12/26/2013Luke BesharCFOSell37,874$30.02$1,136,977.48View SEC Filing  
12/23/2013James GroningerDirectorSell3,000$29.50$88,500.00View SEC Filing  
12/18/2013Ed StratemeierSVPSell205,432$25.13$5,162,506.16View SEC Filing  
9/20/2013Luke BesharCFOSell50,000$30.26$1,513,000.00View SEC Filing  
9/16/2013Joseph RogusVPSell25,312$28.11$711,520.32View SEC Filing  
9/16/2013Luke BesharCFOSell50,000$27.89$1,394,500.00View SEC Filing  
8/30/2013Roger GarceauCMOSell110,000$25.18$2,769,800.00View SEC Filing  
8/20/2013James GroningerDirectorSell16,900$23.21$392,249.00View SEC Filing  
5/9/2013Luke M BesharCFOSell45,150$14.18$640,227.00View SEC Filing  
11/15/2012Glenn R MelroseSVPBuy11,000$9.09$99,990.00View SEC Filing  
10/3/2012Roger GarceauCMOSell140,625$9.51$1,337,343.75View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NPS Pharmaceuticals (NASDAQ:NPSP)
DateHeadline
zacks.com logoShire (SHPG) Gets EU Nod for Label Expansion of Revestive (NASDAQ:NPSP)
www.zacks.com - July 8 at 6:34 PM
fiscalstandard.com logoNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NPSP)
www.fiscalstandard.com - June 27 at 10:43 AM
fiscalstandard.com logoNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Current Analyst Ratings - Fiscal Standard (NASDAQ:NPSP)
www.fiscalstandard.com - June 23 at 7:01 PM
fxpips.com logoGaps Up Stocks Summary, June 3 - TLOG, RXDX, VLTC, CONN, PL, GIGA, NPSP - FxPips.com (NASDAQ:NPSP)
www.fxpips.com - June 3 at 6:59 PM
fxpips.com logoGaps Up Stocks Summary, June 3 – TLOG, RXDX, VLTC, CONN, PL, GIGA, NPSP (NASDAQ:NPSP)
www.fxpips.com - June 3 at 9:21 AM
seekingalpha.com logoA Deep Dive Into Shire's Business - Seeking Alpha (NASDAQ:NPSP)
seekingalpha.com - May 30 at 4:40 PM
News IconNext Weeks Broker Price Targets For NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - May 30 at 4:40 PM
bloomberg.com logoShire Quarterly Profit Tops Estimates as Drug Sales Soar (1) (NASDAQ:NPSP)
washpost.bloomberg.com - May 1 at 3:04 AM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Updated Broker Price Targets - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - April 28 at 10:15 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - April 24 at 5:19 PM
News IconBroker Roundup For NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - April 22 at 5:04 PM
bloomberg.com logoCompany Overview of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
www.bloomberg.com - April 11 at 10:07 PM
News IconLatest Analyst Reports On NPS Pharmaceuticals, Inc. - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - April 8 at 4:56 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Updated Analyst Coverage - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - April 5 at 4:53 PM
News IconAfter Last Week What Do Analysts Think Of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - April 3 at 4:33 PM
News IconMorning Broker Update: NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - April 1 at 4:59 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Updated Broker Ratings - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - March 30 at 4:55 PM
News IconThis Weeks Broker Price Targets For NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - March 28 at 9:40 PM
seekingalpha.com logoSmart-Money Healthcare Investing Focuses On Major Biotech Stocks - Seeking Alpha (NASDAQ:NPSP)
seekingalpha.com - March 28 at 4:33 PM
ftsenews.co.uk logoNew Broker Ratings For NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - FTSE News (NASDAQ:NPSP)
www.ftsenews.co.uk - March 21 at 4:55 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Updated Price Targets - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - March 18 at 4:51 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Analyst Updates - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - March 15 at 4:46 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) New Analyst Ratings ... - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - March 11 at 4:30 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) New Analyst Ratings - Share Trading News (NASDAQ:NPSP)
www.sharetrading.news - March 4 at 4:22 PM
News IconNPS Pharmaceuticals, Inc. (NASDAQ:NPSP) Broker Views - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - March 3 at 4:22 PM
biz.yahoo.com logoNPS Pharmaceuticals, Inc. Company Profile (NASDAQ:NPSP)
biz.yahoo.com - February 25 at 4:46 PM
law360.com logoChancery OKs Shareholder Deal On $5.2B NPS-Shire Sale (NASDAQ:NPSP)
www.law360.com - February 19 at 9:01 AM
News IconRecent Broker Updates On NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - February 16 at 8:58 AM
News IconShire Delivers Record Full-year Revenue & Strong Double Digit Growth In Non GAAP Diluted Earnings Per ADS. Las Vegas Blog (NASDAQ:NPSP)
www.lasvegasnvblog.com - February 11 at 3:48 PM
bloomberg.com logoShire Fourth-Quarter Earnings Exceed Analysts' Expectation (NASDAQ:NPSP)
www.bloomberg.com - February 11 at 9:02 AM
News IconLatest Analysts Reports On NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) - Risers & Fallers (NASDAQ:NPSP)
www.risersandfallers.com - February 5 at 3:40 PM
News IconBaxalta acquired by Shire Pharmaceuticals (NASDAQ:NPSP)
www.rockdalecitizen.com - January 16 at 3:45 PM
finance.yahoo.com logoWill NPS Pharmaceuticals (NPSP) Miss on Earnings in Q4? - Analyst Blog (NASDAQ:NPSP)
finance.yahoo.com - February 16 at 1:00 PM
finance.yahoo.com logoShire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog (NASDAQ:NPSP)
finance.yahoo.com - February 13 at 9:54 AM
investors.com logoShire Moves Up On NPS Potential; Q4 Earnings Miss (NASDAQ:NPSP)
news.investors.com - February 12 at 10:45 AM
sg.finance.yahoo.com logoShire confident on 2015 after NPS deal, binge-eating drug approval (NASDAQ:NPSP)
sg.finance.yahoo.com - February 12 at 9:14 AM
uk.finance.yahoo.com logoShire sees mid-single earnings growth in 2015 (NASDAQ:NPSP)
uk.finance.yahoo.com - February 12 at 7:17 AM
uk.finance.yahoo.com logoShire target NPS Pharma wins FDA approval for Natpara (NASDAQ:NPSP)
uk.finance.yahoo.com - January 26 at 3:43 AM
uk.finance.yahoo.com logoShire shares jump as drug approval vindicates $5.2 bln NPS purchase (NASDAQ:NPSP)
uk.finance.yahoo.com - January 26 at 3:16 AM
uk.finance.yahoo.com logoU.S. FDA approves NPS drug, in move validating Shire takeover deal (NASDAQ:NPSP)
uk.finance.yahoo.com - January 23 at 7:39 PM
finance.yahoo.com logoFDA approves NPS drug, in move validating Shire takeover deal (NASDAQ:NPSP)
finance.yahoo.com - January 23 at 7:00 PM
thestreet.com logo[video]Jim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's Losses (NASDAQ:NPSP)
www.thestreet.com - January 12 at 8:32 PM
finance.yahoo.com logoU.S. equities end lower... (NASDAQ:NPSP)
finance.yahoo.com - January 12 at 4:45 PM
uk.finance.yahoo.com logoShire acquires US rival NPS Pharmaceuticals for $5.2bn (NASDAQ:NPSP)
uk.finance.yahoo.com - January 12 at 8:18 AM
uk.finance.yahoo.com logoNPS a "natural fit" for pharma group Shire, says UBS (NASDAQ:NPSP)
uk.finance.yahoo.com - January 12 at 6:21 AM
finance.yahoo.com logoCramer: Hold Your Fire (NASDAQ:NPSP)
finance.yahoo.com - January 12 at 5:17 AM
finance.yahoo.com logoShire to buy NPS for $5.2 billion to boost rare disease drugs (NASDAQ:NPSP)
finance.yahoo.com - January 11 at 3:27 PM
finance.yahoo.com logoShire to buy NPS for $5.2 bln to boost rare disease drugs (NASDAQ:NPSP)
finance.yahoo.com - January 11 at 3:25 PM
finance.yahoo.com logoShire to buy specialty drugmaker NPS Pharma for $5.2 billion (NASDAQ:NPSP)
finance.yahoo.com - January 11 at 1:27 PM
finance.yahoo.com logoShire considering bid for NPS Pharmaceuticals - Bloomberg (NASDAQ:NPSP)
finance.yahoo.com - December 17 at 12:06 PM

Social

NPS Pharmaceuticals (NASDAQ:NPSP) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff